Literature DB >> 15644946

Cytochrome p450 enzymes and cardiovascular disease.

Arwen L Hunter1, Rani P Cruz, Bo M Cheyne, Bruce M McManus, David J Granville.   

Abstract

The cytochrome p450 (CYP) superfamily is responsible for the oxidation, peroxidation, and (or) reduction of vitamins, steroids, xenobiotics, and the majority of cardiovascular drugs in an oxygen- and NADPH-dependent manner. Although hepatic CYP have been studied extensively, the role of CYP in cardiovascular physiology and disease is poorly understood. Increasing evidence suggests that these enzymes play an important role in the pathogenesis of a number of cardiovascular diseases. The current review summarizes the understanding as to the role that dysregulated CYP expression and (or) activity may play in the onset and progression of cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15644946     DOI: 10.1139/y04-118

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  7 in total

Review 1.  Bimodal targeting of microsomal cytochrome P450s to mitochondria: implications in drug metabolism and toxicity.

Authors:  Michelle C Sangar; Seema Bansal; Narayan G Avadhani
Journal:  Expert Opin Drug Metab Toxicol       Date:  2010-10       Impact factor: 4.481

Review 2.  Bimodal targeting of cytochrome P450s to endoplasmic reticulum and mitochondria: the concept of chimeric signals.

Authors:  Narayan G Avadhani; Michelle C Sangar; Seema Bansal; Prachi Bajpai
Journal:  FEBS J       Date:  2011-10-24       Impact factor: 5.542

3.  Sulfaphenazole protects heart against ischemia-reperfusion injury and cardiac dysfunction by overexpression of iNOS, leading to enhancement of nitric oxide bioavailability and tissue oxygenation.

Authors:  Mahmood Khan; Iyyapu K Mohan; Vijay K Kutala; Sainath R Kotha; Narasimham L Parinandi; Robert L Hamlin; Periannan Kuppusamy
Journal:  Antioxid Redox Signal       Date:  2009-04       Impact factor: 8.401

4.  New Molecular Mechanism Underlying Myc-Mediated Cytochrome P450 2E1 Upregulation in Apoptosis and Energy Metabolism in the Myocardium.

Authors:  Feifei Guan; Xinlan Yang; Jing Li; Wei Dong; Xu Zhang; Ning Liu; Shan Gao; Jizheng Wang; Lianfeng Zhang; Dan Lu
Journal:  J Am Heart Assoc       Date:  2019-01-08       Impact factor: 5.501

5.  The development of novel cytochrome P450 2J2 (CYP2J2) inhibitor and the underlying interaction between inhibitor and CYP2J2.

Authors:  Xiangge Tian; Meirong Zhou; Jing Ning; Xiaopeng Deng; Lei Feng; Huilian Huang; Dahong Yao; Xiaochi Ma
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

6.  Influence of CYP4F2, ApoE, and CYP2A6 gene polymorphisms on the variability of Warfarin dosage requirements and susceptibility to cardiovascular disease in Jordan.

Authors:  Laith N Al-Eitan; Ayah Y Almasri; Adan H Alnaamneh; Hatem A Aman; Nasr N Alrabadi; Rame H Khasawneh; Mansour A Alghamdi
Journal:  Int J Med Sci       Date:  2021-01-01       Impact factor: 3.738

7.  Mechanism of Chinese Medicine Herbs Effects on Chronic Heart Failure Based on Metabolic Profiling.

Authors:  Kuo Gao; Huihui Zhao; Jian Gao; Binyu Wen; Caixia Jia; Zhiyong Wang; Feilong Zhang; Jinping Wang; Hua Xie; Juan Wang; Wei Wang; Jianxin Chen
Journal:  Front Pharmacol       Date:  2017-11-22       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.